New Trials

October 14, 2019

Now Enrolling: Trial EAZ171 is addressing an important survivorship issue…neuropathy in African American women with breast cancer

Recently Activated: Trial EAZ171 is addressing an important survivorship issue...neuropathy in African American women with breast cancer.
February 9, 2020
green awareness ribbon hope

Now Enrolling: Trial EA4181 is comparing three different chemotherapy treatments for newly diagnosed mantle cell lymphoma

Right now, researchers do not know the ideal treatment for people with newly diagnosed mantle cell lymphoma.
June 7, 2020

Now Enrolling: The CompassHER2 pCR trial is determining if certain patients with early-stage HER2 positive breast cancer may benefit from reduced chemotherapy

The purpose of this study is to find out if some patients with early-stage HER2 positive breast cancer can safely be treated with less chemotherapy than is generally used.
June 8, 2020

Now Enrolling: The DECREASE trial seeks to decrease treatment side effects – and improve quality of life – for people with early-stage anal cancer

This study is evaluating whether lower doses of chemoradiation will be able to effectively treat early-stage anal squamous cell carcinoma while also decreasing side effects.